What is the ticker symbol for Immix Biopharma?

Immix Biopharma trades under the ticker IMMX on NASDAQ.

What sector does Immix Biopharma operate in?

Immix Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMMX in a portfolio?

PortView shows IMMX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Immix Biopharma (IMMX) Stock Analysis

NASDAQHealthcareBiotechnology

$13.54-3.35%

1-year price historyRange $1.96 – $14.47

52-week range$13.54

$1.94$15.10

What Immix Biopharma does

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They are also developing IMX-111, a targeted biologic agent for colorectal cancers, and IMX-120, another tissue-specific biologic designed to address ulcerative colitis and severe Crohn's disease. In a strategic move, the company has forged a clinical collaboration and supply agreement with BeiGene Ltd. This partnership aims to conduct a Phase 1b combination clinical trial, evaluating IMX-110 in conjunction with BeiGene's anti-PD-1 drug, Tislelizumab, for solid tumor indications. Founded in 2012, Immix Biopharma maintains its headquarters in Los Angeles, California.

Key metrics

Market cap

$736.60M

P/E (TTM)

-14.88

EPS (TTM)

$-0.91

Beta

0.11

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$10.78

200-day avg

$8.36

52-week high

$15.10

52-week low

$1.94

CEO

Ilya Rachman

ETFs linked to IMMX

Broad-market and Healthcare sector ETFs an investor holding Immix Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IMMX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IMMX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Immix Biopharma?: Immix Biopharma trades under the ticker IMMX on NASDAQ.
Which exchange is IMMX listed on?: IMMX is listed on NASDAQ.
What sector does Immix Biopharma operate in?: Immix Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IMMX in a portfolio?: PortView shows IMMX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.